Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec 12;12(12):CD007481.
doi: 10.1002/14651858.CD007481.pub3.

Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis

Reshma Amin  1 , Peadar G Noone, Felix Ratjen
Affiliations
Review

Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis

Reshma Amin et al. Cochrane Database Syst Rev. .

Abstract

Background: Pneumothorax is a potentially life-threatening complication for people with cystic fibrosis. Spontaneous pneumothorax is the presence of air in the pleural space and can be subdivided into first episode and recurrent. The recurrence of pneumothorax is when it occurs on the same side seven days or more after initial resolution. A pneumothorax is persistent if the air leak lasts for more than five days (Schidlow 1993). Managing spontaneous pneumothoraces is controversial and there is no standard treatment. Medical and surgical intervention are the two main categories for the treatment of recurrent pneumothoraces in people with cystic fibrosis. While surgical interventions are felt to be more effective in people without cystic fibrosis, the complications directly related to the procedure, as well as the post-operative complications make surgical interventions riskier for people with cystic fibrosis. Additionally, these interventions have the potential to make people with cystic fibrosis ineligible for lung transplantation in the future. Therefore, the benefits and side effects or disadvantages for the medical and surgical treatment of recurrent pneumothoraces in people with cystic fibrosis need to be systematically reviewed.

Objectives: To determine the clinical efficacy and safety of different treatment interventions for managing spontaneous persistent and recurrent pneumothoraces in people with cystic fibrosis.

Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises references identified from comprehensive electronic database searches, handsearches of relevant journals and abstract books of conference proceedings.Date of the most recent search: 29 October 2012.

Selection criteria: Randomised and quasi-randomised controlled trials which compared the use of chemical pleurodesis to surgical interventions for the treatment of persistent and recurrent pneumothoraces in CF.

Data collection and analysis: No relevant trials were identified.

Main results: No trials were included in this review

Authors' conclusions: Pneumothorax is a potentially life-threatening complication for people with cystic fibrosis and the management of spontaneous pneumothoraces remains a topic of considerable controversy. Medical and surgical intervention are the two main categories for the treatment of recurrent pneumothoraces in this population. However, it is disappointing that neither intervention has been assessed by randomised controlled trials. This systematic review identifies the need for a multicentre randomised controlled trial assessing both efficacy and possible adverse effects of the use of chemical pleurodesis versus surgical interventions for the treatment of persistent and recurrent pneumothoraces in people with cystic fibrosis.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

Similar articles

See all similar articles

Cited by

  • Pneumothorax in cystic fibrosis.
    Kioumis IP, Zarogoulidis K, Huang H, Li Q, Dryllis G, Pitsiou G, Machairiotis N, Katsikogiannis N, Papaiwannou A, Lampaki S, Porpodis K, Zaric B, Branislav P, Mpoukovinas I, Lazaridis G, Zarogoulidis P. Kioumis IP, et al. J Thorac Dis. 2014 Oct;6(Suppl 4):S480-7. doi: 10.3978/j.issn.2072-1439.2014.09.27. J Thorac Dis. 2014. PMID: 25337406 Free PMC article. Review.

References

Additional references

Aelony 1995
    1. Aelony Y. Talc pleurodesis. Talc slurry versus talc poudrage. Chest 1995;108(1):289. - PubMed
Bresticker 1993
    1. Bresticker MA, Oba J, LoCicero J. Optimal pleurodesis: a comparative study. Annals of Thoracic Surgery 1993;55(2):364‐6. - PubMed
Colt 1994
    1. Colt H, Dumon JF. Development of a disposable spray canister for talc pleurodesis. A preliminary report. Chest 1994;106(6):1776‐80. - PubMed
Colt 1997
    1. Colt HG, Russack V, Chiu Y, Konopka RG, Chiles PG, Pedersen CA, et al. A comparison of thoracoscopic talc insufflation, slurry and mechanical abrasion pleurodesis. Chest 1997;111(2):442‐8. - PubMed
Cystic Fibrosis Foundation 2002
    1. Cystic Fibrosis Foundation. Patient registry 2001: annual data report. Cystic Fibrosis Foundation 2002.
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Wothington HV, Vail A. Meta‐analysis involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):1902‐9. - PubMed
Flume 2005
    1. Flume PA, Strange C, Ye X, Ebeling M, Hulsey T, Clark LL. Pneumothorax in cystic fibrosis. Chest 2005;128(2):720‐8. [PUBMED: 16100160] - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane‐handbook.org.
Schidlow 1993
    1. Schidlow D, Taussig L, Knowles M. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatric Pulmonology 1993;15(3):187‐98. - PubMed
Tschopp 2006
    1. Tschopp JM, Rami‐Porta R, Noppen M, Astoul P. Management of spontaneous pneumothorax: state of the art. European Respiratory Journal 2006;28(3):637‐50. - PubMed

References to other published versions of this review

Amin 2009
    1. Amin R, Noone PG, Ratjen F. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007481. DOI: 10.1002/14651858.CD007481.pub2. [DOI: 10.1002/14651858.CD007481.pub2] - DOI - PubMed